The Efficacy and Safety of Hydroxychloroquine in Patients with COVID-19: A Multicenter National Retrospective Cohort

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology

(2020) Eva Schrezenmeier et al.   Nature Reviews Rheumatology

Predictors for Severe COVID-19 Infection

(2020) Ashish Bhargava et al.   CLINICAL INFECTIOUS DISEASES

COVID‐19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose‐6‐phosphate dehydrogenase deficiency

(2020) Yan Beauverd et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Association between age and clinical characteristics and outcomes of COVID-19

(2020) Yang Liu et al.   EUROPEAN RESPIRATORY JOURNAL

Fatal arrhythmias: Another reason why doctors remain cautious about chloroquine/hydroxychloroquine for treating COVID-19

(2020) Ilija Uzelac et al.   HEART RHYTHM

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

(2020) Philippe Gautret et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State

(2020) Eli S. Rosenberg et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression

(2020) Dan Zhou et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Clinical Characteristics and Outcomes of Older Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: A Single-Centered, Retrospective Study

(2020) TieLong Chen et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Kidney disease is associated with in-hospital death of patients with COVID-19

(2020) Yichun Cheng et al.   KIDNEY INTERNATIONAL

Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19

(2020) Joshua Geleris et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial

(2020) Wei Tang et al.   BMJ-British Medical Journal

Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence

(2020) Jeanne Lenzer   BMJ-British Medical Journal

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

(2020) Tao Chen et al.   BMJ-British Medical Journal

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro

(2020) Jia Liu et al.   Cell Discovery

Liver injury in COVID-19: management and challenges

(2020) Chao Zhang et al.   Lancet Gastroenterology & Hepatology

Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis

(2020) Yue Zhou et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Identification of Symptoms Prognostic of COVID-19 Severity: Multivariate Data Analysis of a Case Series in Henan Province

(2020) Jitian Li et al.   JOURNAL OF MEDICAL INTERNET RESEARCH

In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect

(2020) Julien Andreani et al.   MICROBIAL PATHOGENESIS

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19

(2020) Alexandre B. Cavalcanti et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hydroxychloroquine use in Hospitalized Patients with COVID-19: An observational matched cohort study

(2020) Markos Kalligeros et al.   Journal of Global Antimicrobial Resistance

Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

(2020) Mayla Gabriela Silva Borba et al.   JAMA Network Open

Comparing the impact of Hydroxychloroquine based regimens and standard treatment on COVID-19 patient outcomes: A retrospective cohort study

(2020) Saja H. Almazrou et al.   SAUDI PHARMACEUTICAL JOURNAL

Early prediction of disease progression in COVID-19 pneumonia patients with chest CT and clinical characteristics

(2020) Zhichao Feng et al.   Nature Communications

The Age-Related Risk of Severe Outcomes Due to COVID-19 Infection: A Rapid Review, Meta-Analysis, and Meta-Regression

(2020) Karla Romero Starke et al.   International Journal of Environmental Research and Public Health

Centrality of G6PD in COVID-19: The Biochemical Rationale and Clinical Implications

(2020) Yuliya Buinitskaya et al.   Frontiers in Medicine

Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19

(2020) Wesley H. Self et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)

(2016) Michael F. Marmor et al.   OPHTHALMOLOGY

Hydroxychloroquine reduces heart rate by modulating the hyperpolarization-activated current If: Novel electrophysiological insights and therapeutic potential

(2015) Rebecca A. Capel et al.   HEART RHYTHM

Early Administration of Azithromycin and Prevention of Severe Lower Respiratory Tract Illnesses in Preschool Children With a History of Such Illnesses

(2015) Leonard B. Bacharier et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Ebola Virus and Severe Acute Respiratory Syndrome Coronavirus Display Late Cell Entry Kinetics: Evidence that Transport to NPC1+Endolysosomes Is a Rate-Defining Step

(2015) Rebecca M. Mingo et al.   JOURNAL OF VIROLOGY

Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients

(2013) JC Silva et al.   Clinics

Glucose‐6‐Phosphate Dehydrogenase Deficiency Enhances Human Coronavirus 229E Infection

(2008) Yi‐Hsuan Wu et al.   JOURNAL OF INFECTIOUS DISEASES